Can I read Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate‐term results of the U.S. multicenter clinical trial on EtoBox?

Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate‐term results of the U.S. multicenter clinical trial by Thomas E. Hong; David Thaler; James Brorson; Mary Heitschmidt; Ziyad M. Hijazi is a Medicine article available to read on EtoBox.

What is Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate‐term results of the U.S. multicenter clinical trial about?

## Abstract Closure of patent foramen ovale (PFO) has been proposed as an alternative to anticoagulation in patients with presumed paradoxical emboli. We report the immediate and mid‐term results of the phase 1 U.S. Multicenter Clinical Trial of patients who underwent transcatheter PFO closure for paradoxical embolism using the new Amplatzer PFO device. Fifty patients (28 male/22 female) underwent catheter closure of their PFOs at a mean age of 41 ± 11 years. Thirty‐six patients had ischemic stroke, 10 had transient ischemic attack, and 4 had peripheral embolism. Seventeen patients had atrial septal aneurysm. The implantation procedure was successful in 49/49 patients; one patient did not have a PFO. Complete closure was seen immediately after the procedure in 26/49 patients; 17 had minimal residual shunt, 4 had moderate and 2 had large residual shunts. The median fluoroscopy time was 10.5 min (2.8–43 min). There were no complications related to the device. One patient developed an arteriovenous fistula at the catheter site requiring surgical repair. At a mean follow‐up interval of 16.5 ± 7.2 months, there were no deaths or recurrent neurological or peripheral embolic events. Eight

Who reads Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: Initial and intermediate‐term results of the U.S. multicenter clinical trial?

Author

Thomas E. Hong; David Thaler; James Brorson; Mary Heitschmidt; Ziyad M. Hijazi

Publisher

John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 1522-1946)

Published

2003

Language

EN

Field

Medicine (Health Sciences)